Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths
, M., SSRN, doi:10.2139/ssrn.3575899, Apr 2020
HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.00000000001 from 424 studies, used in 59 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,300+ studies for
210+ treatments. c19early.org
|
Compares the dynamics of daily deaths in the 10 days following the 3rd death in countries using and not using [H]CQ, showing dramatically lower death in [H]CQ countries. This paper does not attempt to account for population age and other differences between the countries and recommends further study.
This study is excluded in the after exclusion results of meta
analysis:
excessive unadjusted differences between groups.
|
risk of death, 85.0% lower, RR 0.15, p < 0.001.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Izoulet et al., 21 Apr 2020, retrospective, multiple countries, preprint, 1 author, dosage not specified.
Abstract: d
Countries which Primarily use Antimalarial Drugs as
5
ev
iew
e
COVID-19 Treatment See Slower Dynamic of daily Deaths
Maxime Izoulet, CEMI-EHESS, Paris.
DOI record:
{
"DOI": "10.2139/ssrn.3575899",
"ISSN": [
"1556-5068"
],
"URL": "http://dx.doi.org/10.2139/ssrn.3575899",
"author": [
{
"affiliation": [],
"family": "Izoulet",
"given": "Maxime",
"sequence": "first"
}
],
"container-title": "SSRN Electronic Journal",
"container-title-short": "SSRN Journal",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2020,
4,
16
]
],
"date-time": "2020-04-16T11:31:03Z",
"timestamp": 1587036663000
},
"deposited": {
"date-parts": [
[
2020,
4,
16
]
],
"date-time": "2020-04-16T11:31:32Z",
"timestamp": 1587036692000
},
"indexed": {
"date-parts": [
[
2023,
10,
30
]
],
"date-time": "2023-10-30T17:55:07Z",
"timestamp": 1698688507990
},
"is-referenced-by-count": 8,
"issued": {
"date-parts": [
[
2020
]
]
},
"language": "en",
"member": "78",
"original-title": [],
"prefix": "10.2139",
"published": {
"date-parts": [
[
2020
]
]
},
"published-other": {
"date-parts": [
[
2020
]
]
},
"publisher": "Elsevier BV",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.ssrn.com/abstract=3575899"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths",
"type": "journal-article"
}
